Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 160 Posts
1 2 3 ... 10
Stocks Are Heading Lower On September 10 Ahead Of The ECB
Article By: Michael J. Kramer Thursday, September 10, 2020 7:16 AM EDT
Stocks are trading lower this morning ahead of the ECB rate announcement.
In this article: REGN, GILD, VRTX, SPY
E Market Briefing For Thursday, August 20
Article By: Gene Inger Thursday, August 20, 2020 2:50 AM EDT
Health heaviness holds the Fed to a defensive stance while they express concern indirectly about systemic stability, and even higher yields 'pulling' policy shifts later in the course of developments; or sort of hinted-at by their oblique comments.
In this article: BA, SRNE, REGN, AAPL, GILD, INTC, NVDA, ORCL Also: VIX, SPX
5 Top-Ranked Stocks Driving ETF As S&P 500 Nears New Highs
Article By: Sweta Killa Thursday, August 13, 2020 12:00 PM EDT
Though most stocks in the fund’s portfolio are in the green this year, here are five that are leading the way in the SPY ETF.
In this article: ROL, WST, REGN, CDNS, PYPL Also: SPY
Regeneron (REGN) Tops Q2 Earnings And Revenue Estimates
Article By: Zacks Investment Research Wednesday, August 5, 2020 10:09 AM EDT
Regeneron came out with quarterly earnings of $7.16 per share.
In this article: REGN
REGN Flat Despite Covid-19 Antibody Drug Update
Article By: Schaeffers Research Tuesday, August 4, 2020 11:00 AM EDT
The equity is up over 115% year-over-year.
In this article: REGN
Quick Reminder: Insider Trading Does Not Maximize Shareholder Value
Article By: Dean Baker Sunday, July 26, 2020 7:39 PM EDT
Insider trading effectively means top executives are stealing from the companies they run. Excitement over potential covid vaccines may be causing irregularities at at least 9 biopharmas, according to the NYT.
Allakos Drops After Regeneron Eosinophilic Esophagitis Study Hits Endpoints
Article By: The Fly Tuesday, May 26, 2020 12:17 PM EDT
Shares of Allakos are lower after Regeneron Pharmaceuticals announced yesterday that Part A of a Phase 3 trial evaluating Dupixent in patients 12 years and older with eosinophilic esophagitis met both of its co-primary endpoints.
In this article: REGN, ALLK
Sanofi To Sell Investment In Regeneron, Says Will Not Impact Collaboration
Article By: The Fly Monday, May 25, 2020 3:22 PM EDT
Sanofi announced its intent to sell its equity investment in Regeneron Pharmaceuticals through a registered public offering. The registered offering and share repurchase will have no impact on the ongoing collaboration between the two.
In this article: SNY, REGN
Regeneron's (REGN) Q1 Earnings & Sales Surpass Estimates
Article By: Zacks Investment Research Tuesday, May 5, 2020 10:54 AM EDT
Regeneron Pharmaceuticals, Inc. reported better-than-expected results for the first quarter of 2020, wherein both earnings and sales beat estimates.
In this article: REGN Also: NVS, SNY, BAYRY
S&P Sees Worst-Ever Q1: 5 Stocks That Gained In The ETF
Article By: Sweta Killa Wednesday, April 1, 2020 1:24 PM EDT
Let’s take a closer look at the fundamentals of SPY and its best stocks.
In this article: CLX, DLR, REGN, CTXS, NFLX Also: SPY
Drugmakers Test New Ways To Fight Coronavirus: 3 Stocks To Pick Up Now
Article By: Eddy Elfenbein Tuesday, March 31, 2020 6:24 AM EDT
On September 2011, the world changed. The acts of terrorism in New York, Washington, and Pennsylvania not only destroyed buildings and lives, but changed both what and how we do a number of activities.
In this article: RHHBY, REGN, GILD
5 Biotechs In Search Of A Coronavirus Vaccine
Article By: Friday, March 20, 2020 8:36 AM EDT
In serious situations like this, the FDA would certainly fast-track any promising cure or vaccine that is submitted. But even that implies a lengthy delay. Many companies are racing to be the first out of the gate. Here are some of them.
In this article: SNY, INO, REGN, GILD, MRNA
5 Stocks In The S&P 500 ETF Still Up YTD
Article By: Sweta Killa Wednesday, March 18, 2020 9:41 PM EDT
Though most stocks in the fund’s portfolio are in red from the year-to-date look, there are a few that are standing tall in the ongoing market turmoil.
In this article: CLX, KR, ROL, REGN, SBAC Also: SPY
Regeneron Downgraded To Neutral From Outperform At Baird
Article By: The Fly Wednesday, February 26, 2020 6:10 AM EDT
Baird analyst Brian Skorney downgraded Regeneron Pharmaceuticals to Neutral from Outperform with an unchanged price target of $410.
In this article: REGN Also: NVS
7 Monster Stock Market Predictions For The Week Of December 9th
Article By: Michael J. Kramer Sunday, December 8, 2019 4:38 PM EDT
Stocks will try to pick up where they left off on Monday, following the strong jobs report. This week will feature CPI, PPI, the Fed, and the ECB. With that, the S&P 500 will try to advance to 3,200 its next level of significant resistance.
In this article: ILMN, REGN, GILD, NFLX, SWKS, TSLA
8 Monster Stock Market Predictions For The Week Of November 25
Article By: Michael J. Kramer Monday, November 25, 2019 5:14 AM EDT
It will be a holiday-shortened trading week with the markets closed on Thursday for Thanksgiving and will close early on Friday. It will likely make for a quiet week of trading.
In this article: ACAD, AAPL, MSFT, TSLA, SPX, GE, REGN
1 to 16 of 160 Posts
1 2 3 ... 10